(Stroke. 1995;26:1659-1664.)
© 1995 American Heart Association, Inc.
Articles |
From the Department of Neurosurgery, Kanazawa University School of Medicine (Japan).
Correspondence to Kazuya Futami, MD, Department of Neurosurgery, Kanazawa University School of Medicine, 13-1 Takaramachi, Kanazawa 920, Japan.
| Abstract |
|---|
|
|
|---|
Methods Cerebral aneurysms were induced in rats by both the ligation of the unilateral common carotid artery and induced hypertension. Intimal proliferation in aneurysmal walls was induced by the ligation of the preserved common carotid artery 3 months after the first operation. The distribution of fibronectin was examined by immunohistochemistry in anterior cerebral arteryolfactory artery bifurcations under the following three conditions: normal bifurcations in control rats, early aneurysmal lesions during the aneurysm induction, and aneurysmal lesions with intimal proliferation. Furthermore, the immunohistochemical distributions of type I and IV collagens were examined to evaluate the specificity of fibronectin immunoreactivity.
Results In the normal bifurcations, fibronectin was positive in the subintimal space, the surrounding area of the medial smooth muscle cells, and the adventitial fibrous tissue. In early aneurysmal lesions, linear staining of fibronectin and type I and IV collagens in the subendothelial space disappeared with the loss of the internal elastic lamina. In the intimal proliferation of early aneurysmal lesions, fibronectin was strongly immunostained in the subendothelial space and diffusely immunostained in the widened extracellular space surrounding proliferated cells. In contrast, the stainings of type I and IV collagens were sparse or negative.
Conclusions Although the present findings regarding dynamic changes of fibronectin distribution do not prove any causality in the process of aneurysm formation and repair, these immunohistochemical changes may constitute the crucial sequela of intimal endothelial damage and its subsequent recovery in cerebral aneurysms.
Key Words: rats cerebral aneurysm collagen fibronectin immunohistochemistry
| Introduction |
|---|
|
|
|---|
In previous reports,1 2 7 proliferative repair in the wall of experimental aneurysmal lesions was induced by various methods, such as decrease of hemodynamic stress,1 administration of blood coagulation factor XIII,1 2 or administration of basic fibroblast growth factor.7 In the most advanced cases, the aneurysmal lumens were completely filled with proliferated cells and matrix substance.1 2 7 These findings indicate the therapeutic possibility of preventing the development of cerebral aneurysms or inducing thickening of the aneurysmal wall with the use of certain factors that facilitate wound healing. Furthermore, they indicate the importance of elucidating the mechanism of intimal proliferation in the cerebral aneurysmal wall to investigate such factors.
Fibronectin is a noncollagenous extracellular matrix glycoprotein and one of the factors that promotes wound healing through its facilitating effects of cell adhesion or migration.8 9 10 11 In arterial walls, fibronectin can be produced by endothelial cells,12 smooth muscle cells,13 and fibroblasts14 and exists in all layers of the walls.15 It has been shown to be strongly immunostained in the early stage of atherosclerosis15 16 and the proliferative response after vascular injury.17 In the present study we investigated changes in fibronectin immunoreactivity in early aneurysmal lesions during both the formation and the proliferative repair of aneurysmal walls experimentally induced in rats. Additionally, the immunohistochemical distribution of type I and IV collagens was examined to evaluate the specificity of fibronectin distribution.
| Materials and Methods |
|---|
|
|
|---|
After the perfusion fixations, the major arteries at the base of the brain were carefully dissected under a surgical microscope. The specimens were further immersed in 4% paraformaldehyde in PBS for 24 hours. After dehydration in graded alcohol, the specimens were embedded in paraffin, and sections 4 µm thick were cut. Using the specimens stained by elasticavan Gieson stain, we performed a microscopic examination of the right ACA-OA bifurcations.
Definition of Aneurysmal Changes
Aneurysmal changes were defined as lesions
representing the outward dilatation of the wall that were
accompanied by discontinuity of the internal elastic lamina in more
than half the length of the dilated wall. The lesions were classified
into two stages: (1) a stage of early aneurysmal lesion
preserving the smooth muscle cell layer in the whole length of the
dilated wall and (2) a stage of saccular aneurysm lacking the
smooth muscle cell layer in even a part of the entire length of the
lesion. The lesions accompanied by intimal proliferation were defined
as those with a cellular component existing between
endothelial cells and the residual internal elastic
lamina. Using the serial sections of normal ACA-OA bifurcations in
control rats, the early aneurysmal lesions in group 1, and the
early aneurysmal lesions accompanied by intimal proliferation
in group 2, we performed the following immunohistochemical
analysis.
Immunohistochemical Analysis
An immunohistochemical analysis was performed with the
use of the avidin-biotin-peroxidase technique. We used rabbit
polyclonal antibodies: A-245 against human fibronectin at a dilution of
1/100, LB-1104 against rat type I collagen at a dilution of 1/400, and
LB-1407 against bovine type IV collagen at a dilution of 1/100. After
the inactivation of intrinsic peroxidase with
H2O2 in methanol and blocking of nonspecific
binding with normal horse serum at a dilution of 1/50, the antibodies
were applied for 24 hours at 4°C to the serial sections. The sections
were then incubated with biotin-labeled horse IgG against rabbit IgG at
a dilution of 1/100 for 1 hour at 37°C, followed by the avidin-biotin
procedure, and counterstained with hematoxylin. The specificity of the
immunostaining was confirmed by replacing the primary
antibody with nonimmune rabbit serum. To control for potential
interanimal variation in the overall degree of immunoreactivity,
immunohistochemical staining was evaluated semiquantitatively by
comparison with the staining intensity of the media in the normal
arterial wall: (-) when negative, (+) when weaker than in
the media, (++) when the same as in the media, and (+++) when stronger
than in the media. When more than two of the three blinded
investigators (O.T., S.H., and T.Y.) made the same evaluation, it was
conclusive.
| Results |
|---|
|
|
|---|
|
Early aneurysmal lesions were observed in none of the control
rats, whereas they were observed in 6 of 13 rats in group 1 (Fig 2A
) and 5 of 12 rats in group 2 (Fig 3A
).
These early aneurysmal lesions were always located in
accordance with the depression shown in normal bifurcations. The wall
of the lesions dilated in various degrees toward the outside of the
artery. Medial smooth muscle cells of the lesions were frequently
thinned and elongated but remained in the entire course of the wall of
the lesions. In these early aneurysmal lesions, none of 6 in
group 1 showed intimal proliferation. In contrast, 3 of 5 in group 2
showed variable degrees of cellular components between the residual
and fragmented internal elastic lamina and a monolayer of
endothelial cells (Fig 3A
). These proliferating cells
were composed of two or three layers of cells that had oval nuclei with
spindle-shaped cytoplasm. In the most advanced cases, proliferated
cells completely filled the original lumen of the lesion and extended
into the subendothelial space along the internal
elastic lamina.
|
|
Saccular aneurysms were absent in all of the control rats. However, 3 of 13 rats in group 1 and 3 of 12 rats in group 2 showed distinct saccular aneurysms (not shown). Medial smooth muscle cells abruptly ended at the orifice of the lesions or were attenuated in the wall of the lesions. The wall of the lesions was mainly composed of endothelial cells and fibrous connective tissue of the adventitia and was prominently dilated outward. Except for the remaining intimal pads, there were no apparent cellular components protruding into the lumen in the subendothelial space, indicating proliferative cells, in the saccular aneurysms in group 1 or 2.
Immunohistochemistry in Normal Control Rats
In the normal ACA-OA junctions of the control rats, fibronectin
was stained as a linear structure in the
subendothelial basal layer, as a fibrillary
structure in the spaces surrounding the medial smooth muscle cells, and
throughout the adventitia (Fig 1B
). In the intimal pads, fibronectin
was stained more strongly than in the media. The
subendothelial linear staining was continuous along
the curvature of the arterial lumen. Similar to the
distribution of fibronectin, type I and IV collagens were present
in the subendothelial basal layer as a linear
staining, in the area surrounding the medial smooth muscle cells as a
fine reticular pattern, and diffusely in the fibrous adventitia (Fig 1C
and 1D
). However, the subendothelial linear
staining was the most obvious in fibronectin within these three
extracellular matrices. In contrast, in the media fibronectin
represented the faintest fibrillary staining compared with
the other proteins. On the other hand, in the diffuse staining in the
adventitia, the staining of type I collagen was apparently more
prominent compared with the others.
Immunohistochemistry of Developing Early Aneurysmal
Lesions
In the early aneurysmal lesions induced in group 1, the
subendothelial linear staining of fibronectin ended
at the entrance of the lesions and completely disappeared in the wall
of the lesions except for occasionally existing segmental fragments of
residual staining (Fig 2B
). The ends of the
subendothelial staining were nearly
consistent with those in the internal elastic lamina under
elasticavan Gieson stain. The staining of fibronectin in the media
and the adventitia of the lesions was not significantly different from
that in the normal ACA-OA bifurcations or that in the other portions of
the artery. Similar to fibronectin staining, the
subendothelial linear staining of type I and IV
collagens also disappeared in the wall of the lesions (Fig 2C
and 2D
).
Immunohistochemistry of Early Aneurysmal Lesions With
Intimal Proliferation
In the wall of the early aneurysmal lesions with intimal
proliferation in group 2, subendothelial linear
staining of fibronectin was observed, although without well-demarcated
configurations (Fig 3B
). Throughout the entire area of intimal
proliferation, fibronectin was diffusely and abundantly stained, except
for scattered proliferated cells. On the other hand, the stainings of
type I and IV collagens in the area of intimal proliferation were
evidently sparse or indistinct compared with those in the other
portions of the artery (Fig 3C
and 3D
).
The Table
summarizes the immunoreactivity of the various
layers constituting the wall of normal ACA-OA bifurcations, early
aneurysmal lesions during development, and early
aneurysmal lesions accompanied by intimal proliferation,
against anti-fibronectin, antitype I collagen, and antitype IV
collagen antibodies.
|
| Discussion |
|---|
|
|
|---|
Fibronectin is not only one of the major mechanical properties of arterial walls but also a multifunctional glycoprotein.8 Fibronectin has been implicated in a variety of cellular properties, particularly those involving the interactions of cells with extracellular matrices.8 In arterial walls, fibronectin is produced by endothelial cells,12 smooth muscle cells,13 and fibroblasts14 and is found in connective tissue matrix and associated with basement membranes24 that underlie endothelial cells and envelop smooth muscle cells. Meanwhile, of 13 distinct subtypes of collagens,25 26 27 six types (I, III, IV, V, VI, and VIII) of collagens are present in arterial walls.28 All of these collagen types except type VIII are known to be synthesized by smooth muscle cells, and all except type VI are synthesized by endothelial cells.28 Types I and III are fibril-forming interstitial collagens that constitute 80% to 90% of total arterial collagen.28 They colocalize in extracellular matrix of the intima, media, and adventitia of normal arteries. Type IV collagen is a constituent of the basement membrane.25
In the present study, considering that fibronectin and type IV collagen concomitantly constitute the basement membrane and that fibronectin and type I collagen exist in the subendothelial connective tissue, the immunohistochemical distributions of type I and IV collagens were examined to evaluate the specificity of fibronectin in the distributional changes. During the development of aneurysmal lesions, fibronectin in the subendothelial space was immunohistochemically demonstrated to disappear together with type I and IV collagens. This finding may represent the degeneration of the endothelial basement membrane and the subendothelial connective tissue. The precise mechanism of these alterations in these extracellular matrices remains unclear. However, it is compatible with the degeneration of endothelial cells in aneurysmal walls demonstrated by scanning electron microscopy.3 4 5 Degenerated endothelial cells may decrease the production of fibronectin or type I and IV collagens. Accordingly, the alterations of the subendothelial extracellular matrices may represent one of the earliest manifestations of endothelial dysfunction.
Fibronectin plays an important role in tissue repair,9 10
showing molecular affinities for collagen,31 hyaluronic
acid,32 and fibrin,33 which are three major
components of early wounds.10 34 Fibronectin in clots
cross-links to the
-chain of fibrin by plasma transglutaminase,
activated blood coagulation factor XIII, during blood
coagulation33 and forms the adhesive sites on the fibrin
molecule to which cells can bind.11 Epidermal cells
contact the fibrin filaments during their migration toward the wound
center.9 Fibroblasts are also chemoattracted by
fibronectin.35 Thus, fibronectin with collagen and
hyaluronic acid in the developing matrix of granulation tissue and with
fibrin in fibrin clots can provide a substratum for migrating cells
that functions to unite the opposed tissues.9 In
arterial walls, fibronectin is strongly
immunostained in the early stage of
atherosclerosis15 16 and proliferative
response after vascular injury.17 Type I collagen also
promotes the migration of fibroblasts.36 Accordingly, the
lack of fibronectin and type I and IV collagens in the
subendothelial space of aneurysmal lesions
may not only increase the mechanical vulnerability of the wall but also
impair wound healing in aneurysmal walls.1 2
Using rats subjected to ligation of the unilateral common carotid artery and renal hypertension, Kang et al1 2 produced intimal proliferation in aneurysmal lesions by three different methods: decreasing hemodynamic stress by the ligation of the nonligated common carotid artery,1 administration of an antihypertensive drug,1 and administration of blood coagulation factor XIII.1 2 We induced a similar intimal proliferation by administration of basic fibroblast growth factor.7 In these experiments, smooth muscle cells were consistently demonstrated to proliferate in the subendothelial space.1 2 7
In the present study we induced intimal proliferation by the ligation of the common carotid artery ipsilateral to the aneurysm formation.1 The incidences of intimal proliferation in the ACA-OA junctions and in aneurysmal changes were 25% and 37.5%, respectively. In immunohistochemistry, we found diffuse staining of fibronectin in the area of the intimal proliferation induced in early aneurysmal lesions. It is likely that fibronectin is an important factor in the repair of aneurysmal lesions. In such cases, fibronectin may provide a substratum for smooth muscle cells to migrate and proliferate in the subendothelial space of the wall. Furthermore, the distinct subendothelial staining of fibronectin in the intimal proliferation may indicate the subsequent recovery of endothelial cells as a result of decreasing hemodynamic stress to aneurysmal lesions.
Received November 23, 1994; revision received March 20, 1995; accepted May 12, 1995.
| References |
|---|
|
|
|---|
2. Kang Y, Hashimoto N, Kikuchi H, Yamazoe N, Hazama F. Effects of blood coagulation factor XIII on the development of experimental cerebral aneurysm in rats. J Neurosurg. 1990;73:242-247. [Medline] [Order article via Infotrieve]
3. Nagata I, Handa H, Hashimoto N, Hazama F. Experimentally induced cerebral aneurysms in rats, VII: scanning electron microscope study. Surg Neurol. 1981;16:291-296. [Medline] [Order article via Infotrieve]
4. Kim C, Cervós-Navarro J, Kikuchi H, Hashimoto N, Hazama F. Alterations in cerebral vessels in experimental animals and their possible relationship to the development of aneurysms. Surg Neurol. 1992;38:331-337. [Medline] [Order article via Infotrieve]
5.
Kojima M, Handa H, Hashimoto N, Kim C, Hazama F.
Early changes of experimentally induced cerebral
aneurysms in rats: scanning electron microscopic study.
Stroke. 1986;17:835-841.
6. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809. [Medline] [Order article via Infotrieve]
7.
Futami K, Yamashita J, Tachibana O, Kida S, Higashi S,
Ikeda K, Yamashima T. Basic fibroblast growth factor may repair
experimental cerebral aneurysms in rats.
Stroke. 1995;26:1649-1654.
8.
Hynes RO, Yamada KM. Fibronectins:
multifunctional molecular glycoproteins.
J Cell Biol. 1982;95:369-377.
9. Repesh LA, Fitzgerald TJ, Furcht LT. Fibronectin involvement in granulation tissue and wound healing in rabbits. J Histochem Cytochem. 1982;30:351-358. [Abstract]
10. Grinnell F, Billingham KE, Burgess L. Distribution of fibronectin during wound healing in vivo. J Invest Dermatol. 1981;76:181-189. [Medline] [Order article via Infotrieve]
11. Grinnell F, Feld M, Minter D. Fibroblast adhesion to fibrinogen and fibrin substrata: requirement for cold-insoluble globulin (plasma fibronectin). Cell. 1980;19:517-525. [Medline] [Order article via Infotrieve]
12.
Jaffe EA, Mosher DF. Synthesis of fibronectin by
cultured human endothelial cells. J
Exp Med. 1978;147:1779-1791.
13.
Hedin U, Bottger BA, Forsberg E, Johansson S, Thyberg
J. Diverse effects of fibronectin and laminin on phenotypic
properties of cultured arterial smooth muscle
cells. J Cell Biol. 1988;107:307-319.
14.
Hedman K, Vaheri A, Wartiovaara J. External
fibronectin of cultured human fibroblasts is predominantly a matrix
protein. J Cell Biol. 1978;76:748-760.
15. Jensen BA, Hølund B, Clemmensen I. Demonstration of fibronectin in normal and injured aorta by an indirect immunoperoxidase technique. Histochemistry. 1983;77:395-403. [Medline] [Order article via Infotrieve]
16. Stenman S, Von Smitten K, Vaheri A. Fibronectin and atherosclerosis. Acta Med Scand. 1980;642(suppl):165-170.
17. Chemnitz J, Collatz Christensen B. Repair in arterial tissue: demonstration of fibronectin in the normal and healing rabbit thoracic aorta by the indirect immunoperoxidase technique. Virchows Arch A Pathol Anat Histopathol. 1983;399:307-316. [Medline] [Order article via Infotrieve]
18. Hashimoto N, Handa H, Hazama F. Experimentally induced cerebral aneurysms in rats. Surg Neurol. 1978;10:3-8. [Medline] [Order article via Infotrieve]
19. Nagata I, Handa H, Hashimoto N, Hazama F. Experimentally induced cerebral aneurysms in rats, part VI: hypertension. Surg Neurol. 1980;14:477-479. [Medline] [Order article via Infotrieve]
20.
Pope FM, Martin GR, Lichtenstein JR, Pentinen R, Gerson
B, Rowe DW, McKusick VA. Patients with Ehlers-Danlos syndrome
type IV lack type III collagen. Proc Natl Acad Sci U S
A. 1975;72:1314-1317.
21. Rubinstein MK, Cohen NH. Ehlers-Danlos syndrome associated with multiple intracranial aneurysms. Neurology. 1964;14:125-132.
22. Neil-Dwyer G, Bartlett JR, Nicholis AC, Narcisi P, Pope FM. Collagen deficiency and ruptured cerebral aneurysms: a clinical and biochemical study. J Neurosurg. 1983;59:16-20. [Medline] [Order article via Infotrieve]
23. Østergaard JR, Oxlund H. Collagen type III deficiency in patients with rupture of intracranial saccular aneurysms. J Neurosurg. 1987;67:690-696. [Medline] [Order article via Infotrieve]
24.
Stenman S, Vaheri A. Distribution of a major
connective tissue protein, fibronectin, in normal human
tissues. J Exp Med. 1978;147:1054-1064.
25. Miller EJ, Gay S. The collagens: an overview and update. Methods Enzymol. 1987;144:3-41. [Medline] [Order article via Infotrieve]
26.
Gordon MK, Gerecke DR, Olsen BR. Type X
collagen: distinct extracellular matrix component discovered by cDNA
cloning. Proc Natl Acad Sci U S A. 1987;84:6040-6044.
27.
Sandberg M, Tamminen M, Hirvonen H, Vuorio E,
Pihlajaniemi T. Expression of mRNAs coding for the
1 chain of type X collagen in human fetal tissues:
comparison with expression of mRNAs for collagen type I, II, and
III. J Cell Biol. 1989;109:1371-1379.
28. Mayne R. Collagenous proteins of blood vessels. Arteriosclerosis. 1986;6:585-593. [Medline] [Order article via Infotrieve]
29. Mayne R. Vascular connective tissue: normal biology and derangement in human diseases. In: Uitto J, Perejda AJ, eds. Connective Tissue Disease: Molecular Pathology of the Extracellular Matrix. New York, NY: Marcel Dekker, Inc; 1987:163-183.
30. Hazama F, Kataoka H, Yamada E, Kayembe K, Hashimoto N, Kojima M, Kim C. Early changes of experimentally induced cerebral aneurysms in rats: light-microscopic study. Am J Pathol. 1986;124:399-404. [Abstract]
31. Engvall E, Ruoslahti E. Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int J Cancer. 1977;20:1-5. [Medline] [Order article via Infotrieve]
32.
Yamada CB, Kennedy DW, Kimata K, Pratt RM.
Characterization of fibronectin interactions with
glycosaminoglycans and identification of active proteolytic
fragments. J Biol Chem. 1980;255:6055-6063.
33. Mosher DF. Cross-linking of cold-insoluble globulin by fibrin stabilizing factor. J Biol. 1975;250:6614-6621.
34. Alexander SA, Donoff RB. A modification of the Alcian blue method for staining hyaluronic acid substances in tissue section. J Histotechnol. 1980;3:41-44.
35.
Postlethwaite AE, Keski-Oja J, Balian G, Kang AH.
Induction of fibroblast chemotaxis by fibronectin: localization
of the chemotactic region to a 140,000-molecular weight
non-gelatin-binding fragment. J Exp Med. 1981;153:494-499.
36.
Postlethwaite AE, Seyer JM, Kang AH. Chemotactic
attraction of human fibroblasts to type I, II, and III collagens and
collagen-derived peptides. Proc Natl Acad Sci U S A. 1978;75:871-875.
This article has been cited by other articles:
![]() |
E. Metaxa, H. Meng, S. R. Kaluvala, M. P. Szymanski, R. A. Paluch, and J. Kolega Nitric oxide-dependent stimulation of endothelial cell proliferation by sustained high flow Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H736 - H742. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Meng, Z. Wang, Y. Hoi, L. Gao, E. Metaxa, D. D. Swartz, and J. Kolega Complex Hemodynamics at the Apex of an Arterial Bifurcation Induces Vascular Remodeling Resembling Cerebral Aneurysm Initiation Stroke, June 1, 2007; 38(6): 1924 - 1931. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Peters, A. B. Kassam, E. Feingold, E. Heidrich-O'Hare, H. Yonas, R. E. Ferrell, and A. Brufsky Molecular Anatomy of an Intracranial Aneurysm : Coordinated Expression of Genes Involved in Wound Healing and Tissue Remodeling Stroke, April 1, 2001; 32(4): 1036 - 1042. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Murayama, F. Viñuela, Y. Suzuki, Y. Akiba, A. Ulihoa, G. R. Duckwiler, Y. P. Gobin, H. V. Vinters, M. Iwaki, and T. Abe Development of the Biologically Active Guglielmi Detachable Coil for the Treatment of Cerebral Aneurysms. Part II: An Experimental Study in a Swine Aneurysm Model AJNR Am. J. Neuroradiol., November 1, 1999; 20(10): 1992 - 1999. [Abstract] [Full Text] |
||||
![]() |
K. Kataoka, M. Taneda, T. Asai, A. Kinoshita, M. Ito, and R. Kuroda Structural Fragility and Inflammatory Response of Ruptured Cerebral Aneurysms : A Comparative Study Between Ruptured and Unruptured Cerebral Aneurysms Stroke, July 1, 1999; 30(7): 1396 - 1401. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Coutard and M. Osborne-Pellegrin Genetic Susceptibility to Experimental Cerebral Aneurysm Formation in the Rat Stroke, May 1, 1997; 28(5): 1035 - 1042. [Abstract] [Full Text] |
||||
![]() |
S. Kondo, N. Hashimoto, H. Kikuchi, F. Hazama, I. Nagata, H. Kataoka, and R. L. Macdonald Cerebral Aneurysms Arising at Nonbranching Sites: An Experimental Study Stroke, February 1, 1997; 28(2): 398 - 404. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |